Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Manulife Financial Corporation (MFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Manulife Financial Corporation — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.47B), while Manulife Financial Corporation trades at $42.93 (market cap $71.51B). The key difference: Manulife Financial Corporation is far larger — about 8.4× Hinge Health Inc. Class A Common Stock's market cap, and Manulife Financial Corporation pays a 3.16% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Manulife Financial Corporation for 120 Days on average.
| HNGE | MFC | |
|---|---|---|
Market Cap | $8.47B | $71.51B |
Volume | 1,624,526 | 1,076,604 |
Sector | Health | Financials |
52-Week High | $105.14 | $44.77 |
52-Week Low | $31.17 | $31.64 |
Typical Hold Time | 0 Days | 120 Days |
Enterprise Value | $8.09B | $66.76B |
Dividend Yield | — | 3.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
MFC trades at $43.28, up 0.98% on the day, with a neutral technical signal and bullish moving averages. Revenue grew to $53.01B in 2025, with a net income margin of 11.7% and a P/E of 16.73. Recent news includes a $145.18M investment by Bank of America and the appointment of a new Global Chief Marketing Officer.
The outlook is supported by strong earnings beats and analyst buy ratings, but risks include premium valuation concerns and macroeconomic sensitivity. Upside potential exists if Q3 2026 earnings meet or exceed expectations, though competition and debt levels warrant caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Manulife Financial Corporation
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →
